Fjarde Ap-fonden’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-295,789
Closed -$2.78M 541
2023
Q1
$2.78M Buy
295,789
+30,400
+11% +$359K 0.04% 416
2022
Q4
$3.24M Buy
265,389
+132,400
+100% +$1.65M 0.05% 398
2022
Q3
$2.61M Hold
132,989
0.03% 470
2022
Q2
$2.61M Sell
132,989
-1,100
-0.8% -$26K 0.03% 470
2022
Q1
$3.5M Hold
134,089
0.03% 462
2021
Q4
$3.81M Sell
134,089
-12,500
-9% -$389K 0.03% 467
2021
Q3
$4.67M Sell
146,589
-3,500
-2% -$117K 0.04% 418
2021
Q2
$5.21M Sell
150,089
-3,700
-2% -$122K 0.05% 399
2021
Q1
$4.53M Hold
153,789
0.04% 430
2020
Q4
$4.72M Buy
153,789
+9,100
+6% +$278K 0.04% 398
2020
Q3
$4.04M Buy
144,689
+3,300
+2% +$83.6K 0.04% 400
2020
Q2
$3.03M Sell
141,389
-5,200
-4% -$115K 0.04% 446
2020
Q1
$3.28M Buy
146,589
+23,600
+19% +$646K 0.05% 360
2019
Q4
$3.62M Buy
122,989
+14,700
+14% +$399K 0.04% 440
2019
Q3
$2.88M Buy
108,289
+22,700
+27% +$681K 0.04% 459
2019
Q2
$2.89M Sell
85,589
-10,400
-11% -$338K 0.04% 474
2019
Q1
$3.08M Buy
+95,989
New +$2.95M 0.04% 455

Other funds holding ELAN

Fjarde Ap-fonden's ELAN Position: Q2 2023 in Review

Fjarde Ap-fonden sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 295,789 shares — an estimated $2.78M sold.

Fjarde Ap-fonden first reported a position in ELAN in Q1 2019 and held it in 17 quarters. The position peaked at $5.21M in Q2 2021. 352 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

  • Fjarde Ap-fonden reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
  • Fjarde Ap-fonden sold 295,789 Elanco Animal Health shares in Q2 2023, an estimated $2.78M.
  • Fjarde Ap-fonden first reported a position in Elanco Animal Health in Q1 2019 and held it in 17 quarters.
  • Fjarde Ap-fonden's Elanco Animal Health position peaked at $5.21M in Q2 2021.
  • 352 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on Fjarde Ap-fonden's 13F filing for Q2 2023, filed 2 Aug 2023.